News
Local
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate News
Hot Property
eNewspaper
________________
Subscriptions
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
About Us
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Events
Advertising
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Jobs
CaregiverSD
Community papers
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Games, Puzzles, and Crossword
Crossword
Sudoku
Crossword
Sudoku
Obituaries
Death Notices
Place an obituary
Death Notices
Place an obituary
U-T En Español
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Privacy and Terms
Privacy
Terms
Advertising terms
Privacy
Terms
Advertising terms
Copyright © 2022, The San Diego Union-Tribune |
CA Notice of Collection
|
Do Not Sell My Personal Information
Sections
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate
Obituaries
eNewspaper
Newsletters
Show Search
Search Query
Submit Search
COVID-19
For subscribers
Phenomenal women
Latino life
Crossword
Sudoku
About Us
Contact us
Community Advisory Board
Readers Rep
Careers
Events
Historical Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
San Diego Stocks
San Diego Stocks
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Health & Science
Recent news which mentions Health & Science
< Previous
1
2
...
10
11
12
13
14
15
16
17
18
...
32
33
Next >
CVS is under pressure and considering a break up. Here's why that could be risky
October 04, 2024
Tags
Cigna Corp
UnitedHealth Group Inc
Pharmaceuticals
From
CNBC.com News
Oura announces new smart ring with updated design and new sensors for $349
October 03, 2024
Tags
AI / Artificial Intelligence
Enterprise
Media
From
CNBC.com News
Recursion gets FDA approval to begin phase 1 trials of AI-discovered cancer treatment
October 02, 2024
Tags
Recursion Pharmaceuticals LLC
AI / Artificial Intelligence
Investment strategy
From
CNBC.com News
Eli Lilly to build $4.5 billion research and manufacturing center to propel drug pipeline
October 02, 2024
Tags
Science
Business
Manufacturing
From
CNBC.com News
Healthy Returns: Pfizer pulls sickle cell disease drug from markets – here’s why it matters
October 01, 2024
Tags
Healthy Returns
UnitedHealth Group Inc
Social issues
From
CNBC.com News
CVS is working with advisors on strategic review, sources say
September 30, 2024
Tags
Health care industry
Health & Science
Pharmaceuticals
From
CNBC.com News
Major CVS shareholder plans activist push, will meet with management, sources say
September 29, 2024
Tags
Centene Corp
Breaking news
Health insurance
From
CNBC.com News
Harris leads with Latino voters, but the economy narrows the margin for Dems: Survey
September 29, 2024
Tags
Health & Science
Breaking News: Markets
Breaking News: Politics
From
CNBC.com News
FDA approves Bristol Myers Squibb's schizophrenia drug, the first new type of treatment in decades
September 26, 2024
Tags
Science
Breaking news
Health & Science
From
CNBC.com News
Novo Nordisk's diabetes drug Ozempic may lower the risk of opioid overdoses, study says
September 25, 2024
Tags
Pharmaceuticals
Companies
Health care industry
From
CNBC.com News
Healthy Returns: Weight loss drug Wegovy could face Medicare price negotiations next
September 24, 2024
Tags
Health & Science
GSK plc
Astellas Pharma Inc
From
CNBC.com News
Novo Nordisk CEO to testify at Senate hearing over high weight loss drug prices
September 24, 2024
Tags
Business
Novo Nordisk A/S
US: News
From
CNBC.com News
FTC sues drug middlemen for allegedly inflating insulin prices
September 20, 2024
Tags
Business
Novo Nordisk A/S
Sanofi SA
From
CNBC.com News
Pesky medical bill? Most people don't take a key step to manage that debt, study finds
September 20, 2024
Tags
Health
Health Insurance
Personal loans
From
CNBC.com News
Novartis not joining the 'frenzy' of weight loss drugs, CEO says
September 18, 2024
Tags
Pfizer Inc
Pharmaceuticals
Health care industry
From
CNBC.com News
23andMe CEO Anne Wojcicki 'surprised and disappointed' by board resignations: Read the memo
September 17, 2024
Tags
23andMe Holding Co/
Enterprise
Internet
From
CNBC.com News
Healthy Returns: How competitive can Roche be in the weight loss drug market?
September 17, 2024
Tags
Biotech and Pharmaceuticals
Healthy Returns
Eli Lilly and Co
From
CNBC.com News
FDA clears Apple's sleep apnea detection feature for use. Here's how it works
September 16, 2024
Tags
Technology
Health care industry
Breaking News: Technology
From
CNBC.com News
Drugmakers bet billions that targeted radiation could become the next cancer breakthrough
September 16, 2024
Tags
AstraZeneca PLC
Eli Lilly and Co
Biotech and Pharmaceuticals
From
CNBC.com News
Pfizer says its experimental drug for deadly condition that causes appetite and weight loss in cancer patients shows positive trial results
September 14, 2024
Tags
Breaking News: Business
Business News
Biotechnology
From
CNBC.com News
Gilead's twice-yearly shot cut HIV infections by 96% in trial
September 12, 2024
Tags
Business News
Gilead Sciences Inc
Social issues
From
CNBC.com News
Apple turning AirPods into hearing aids underscores effort to crack massive health market
September 12, 2024
Tags
Technology
Entertainment
Breaking News: Technology
From
CNBC.com News
Digital health company Noom to offer compounded GLP-1 drug through new weight loss program
September 12, 2024
Tags
Hims & Hers Health Inc
Enterprise
Pharmaceuticals
From
CNBC.com News
Moderna to cut $1.1 billion in costs and launch 10 new products by 2027 as it charts post-Covid future
September 12, 2024
Tags
Health care industry
Health & Science
Companies
From
CNBC.com News
Eli Lilly to invest $1.8 billion to expand manufacturing for weight loss, diabetes and Alzheimer's drugs
September 12, 2024
Tags
Biotechnology
Biotech and Pharmaceuticals
Eli Lilly and Co
From
CNBC.com News
'Economy class syndrome' is a medical issue that can happen on flights — no matter where you sit
September 11, 2024
Tags
Science
CNBC Travel
Heart health
From
CNBC.com News
This government-backed startup is growing blood to help fight shortages
September 11, 2024
Tags
Technology
Enterprise
Breaking News: Technology
From
CNBC.com News
Healthy Returns: More than 50 million privately insured adults could be eligible for GLP-1 drugs
September 10, 2024
Tags
Health & Science
Apple Inc
Health care industry
From
CNBC.com News
AstraZeneca shares fall 5% on disappointing lung cancer drug trial results
September 10, 2024
Tags
Health care industry
Health & Science
Europe News
From
CNBC.com News
Alzheimer's drug Leqembi promises to give patients more time, but they face a long road to treatment
September 08, 2024
Tags
Eisai Co Ltd
Business News
Breaking News: Business
From
CNBC.com News
< Previous
1
2
...
10
11
12
13
14
15
16
17
18
...
32
33
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.